• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
DING Kaiqiang,TIAN Wei,ZHOU Dewang,FENG Shuang,YANG Yong.Advances in the research and development of HIF-1 inhibitors[J].Journal Of Pharmaceutical Research,2017,36(6):344-346,372[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3644times   Download 3470次 QR Code for this article
Scan with your phone!
低氧诱导因子抑制剂的研究进展
丁凯强,田薇,周德旺,冯爽,杨勇
Font:Larger+|Default|Smaller-
(中国药科大学药物科学研究院,江苏 南京 211198)
摘要:
低氧诱导因子(hypoxia inducible factor, HIF)是机体的一种重要的转录因子,在缺氧状态下介导一系列的细胞低氧反应。低氧诱导因子在肿瘤发生发展过程中发挥重要调控作用,同时也介导了肿瘤放化疗抗性并与肿瘤患者不良预后密切相关。因此,低氧诱导因子抑制剂的相关研究对于肿瘤的理解与治疗具有重要意义。本文总结了低氧诱导因子抑制剂研究的3种思路与代表抑制剂,以期为低氧诱导因子抑制剂在肿瘤治疗中的应用奠定基础。
关键词:  低氧诱导因子  缺氧  转录因子  抑制剂  抗肿瘤
DOI:10.13506/j.cnki.jpr.2017.06.010
基金项目:国家自然科学基金青年基金项目(No.81502407);国家自然科学基金(No.81403020);江苏省自然科学基金青年基金项目(No.BK20140666)
Advances in the research and development of HIF-1 inhibitors
DING Kaiqiang,TIAN Wei,ZHOU Dewang,FENG Shuang,YANG Yong
(Drug Research Institute,China Pharmaceutical University, Nanjing 211198, China)
Abstract:
Hypoxia-inducible factor (HIF) is an essential transcription factor, which mediates a hypoxic response at decreased oxygen tensions.HIF plays vital roles in tumor development and progression and meditates tumor resistance to chemotherapy and radiotherapy and is associated with poor prognosis in cancer patients.Therefore, research and development of HIF inhibitors has the potential to improve treatment efficacy.In this article, three ways of targeting HIF-1 were summarized so as to lay the foundation for the therapeutic use of HIF inhibitors.
Key words:  HIF  Hypoxia  Transcription Factor  Inhibitor  Anti-tumor
Today's Visits:487    Total Visits:2383201
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.